PT90716A - Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotonina - Google Patents
Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotoninaInfo
- Publication number
- PT90716A PT90716A PT90716A PT9071689A PT90716A PT 90716 A PT90716 A PT 90716A PT 90716 A PT90716 A PT 90716A PT 9071689 A PT9071689 A PT 9071689A PT 90716 A PT90716 A PT 90716A
- Authority
- PT
- Portugal
- Prior art keywords
- utilian
- aryloxipropanolamine
- derivatives
- preparation
- prepared process
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 1
- 102000035038 5-HT1 receptors Human genes 0.000 abstract 1
- 108091005478 5-HT1 receptors Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/08—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20276788A | 1988-06-03 | 1988-06-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT90716A true PT90716A (pt) | 1989-12-29 |
| PT90716B PT90716B (pt) | 1995-03-01 |
Family
ID=22751177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT90716A PT90716B (pt) | 1988-06-03 | 1989-06-01 | Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotonina |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0345056B1 (pt) |
| JP (2) | JP2806555B2 (pt) |
| KR (1) | KR0132779B1 (pt) |
| CN (1) | CN1023402C (pt) |
| AT (1) | ATE117980T1 (pt) |
| CA (1) | CA1336911C (pt) |
| DE (1) | DE68920913T2 (pt) |
| DK (1) | DK271889A (pt) |
| ES (1) | ES2067541T3 (pt) |
| GR (1) | GR3015297T3 (pt) |
| HU (1) | HUT56056A (pt) |
| IE (1) | IE66225B1 (pt) |
| IL (1) | IL90498A (pt) |
| NZ (1) | NZ229376A (pt) |
| PT (1) | PT90716B (pt) |
| RU (1) | RU1795965C (pt) |
| ZA (1) | ZA894145B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
| US5258379A (en) * | 1990-05-04 | 1993-11-02 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with n-arylpiperazines |
| US5340838A (en) * | 1990-05-04 | 1994-08-23 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines |
| IL110857A0 (en) * | 1993-09-09 | 1994-11-28 | Lilly Co Eli | Cessation of tobacco use |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| US6075040A (en) | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| EP0827746B1 (en) * | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| FR2780057B1 (fr) * | 1998-06-18 | 2002-09-13 | Sanofi Sa | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2817257B1 (fr) * | 2000-11-30 | 2009-03-20 | Sanofi Synthelabo | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant |
| FR2840301B1 (fr) * | 2002-05-29 | 2007-03-23 | Sanofi Synthelabo | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3471515A (en) * | 1965-02-01 | 1969-10-07 | Sandoz Ag | (2-hydroxy-3-substituted aminopropoxy)indoles |
| DE1668055B2 (de) * | 1967-03-10 | 1973-09-06 | Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt | Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung |
| US5229412A (en) * | 1988-03-25 | 1993-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Method for relieving anxiety using 5-hydroxytryptamine-1a-receptor-binding compounds |
| JP4920768B2 (ja) | 2010-05-31 | 2012-04-18 | 株式会社東芝 | ニー補正装置及びニー補正方法 |
-
1989
- 1989-06-01 CN CN89103839A patent/CN1023402C/zh not_active Expired - Fee Related
- 1989-06-01 EP EP89305516A patent/EP0345056B1/en not_active Expired - Lifetime
- 1989-06-01 ZA ZA894145A patent/ZA894145B/xx unknown
- 1989-06-01 DE DE68920913T patent/DE68920913T2/de not_active Expired - Fee Related
- 1989-06-01 JP JP1140240A patent/JP2806555B2/ja not_active Expired - Fee Related
- 1989-06-01 IL IL9049889A patent/IL90498A/en not_active IP Right Cessation
- 1989-06-01 RU SU894614121A patent/RU1795965C/ru active
- 1989-06-01 AT AT89305516T patent/ATE117980T1/de active
- 1989-06-01 CA CA000601438A patent/CA1336911C/en not_active Expired - Fee Related
- 1989-06-01 NZ NZ229376A patent/NZ229376A/en unknown
- 1989-06-01 ES ES89305516T patent/ES2067541T3/es not_active Expired - Lifetime
- 1989-06-01 PT PT90716A patent/PT90716B/pt not_active IP Right Cessation
- 1989-06-02 DK DK271889A patent/DK271889A/da not_active Application Discontinuation
- 1989-06-02 HU HU892827A patent/HUT56056A/hu unknown
- 1989-06-02 KR KR1019890007568A patent/KR0132779B1/ko not_active Expired - Fee Related
- 1989-06-12 IE IE181189A patent/IE66225B1/en unknown
-
1995
- 1995-03-03 GR GR950400475T patent/GR3015297T3/el unknown
-
1998
- 1998-03-16 JP JP10065275A patent/JP3050844B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE117980T1 (de) | 1995-02-15 |
| NZ229376A (en) | 1991-07-26 |
| CN1023402C (zh) | 1994-01-05 |
| AU609997B2 (en) | 1991-05-09 |
| EP0345056A3 (en) | 1992-07-01 |
| DE68920913T2 (de) | 1995-06-22 |
| ZA894145B (en) | 1991-02-27 |
| DK271889A (da) | 1989-12-05 |
| EP0345056A2 (en) | 1989-12-06 |
| GR3015297T3 (en) | 1995-06-30 |
| KR910000599A (ko) | 1991-01-29 |
| JPH10273437A (ja) | 1998-10-13 |
| IL90498A (en) | 1995-12-08 |
| JP3050844B2 (ja) | 2000-06-12 |
| IE66225B1 (en) | 1995-12-13 |
| DE68920913D1 (de) | 1995-03-16 |
| CN1045774A (zh) | 1990-10-03 |
| JPH0225416A (ja) | 1990-01-26 |
| RU1795965C (ru) | 1993-02-15 |
| EP0345056B1 (en) | 1995-02-01 |
| JP2806555B2 (ja) | 1998-09-30 |
| DK271889D0 (da) | 1989-06-02 |
| CA1336911C (en) | 1995-09-05 |
| ES2067541T3 (es) | 1995-04-01 |
| HUT56056A (en) | 1991-07-29 |
| KR0132779B1 (ko) | 1998-04-13 |
| AU3601989A (en) | 1989-12-07 |
| PT90716B (pt) | 1995-03-01 |
| IE891811L (en) | 1989-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT93110A (pt) | Processo aperfeicoado para a preparacao de derivados de isoquinolina | |
| PT80717A (en) | Process for preparing benzodiazepine analogs | |
| ES2113368T3 (es) | Antagonistas de serotonina. | |
| PT86980A (pt) | Process for preparing benzodiazepine analogs | |
| SE8400788D0 (sv) | Novel adenosine receptor antagonists | |
| PT90716A (pt) | Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotonina | |
| DK55784A (da) | Xylanderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende xylanderivaterne med antithrombose- og hypolipidaemisk virkning | |
| HUT66596A (en) | Process for preparing piperidine derivatives | |
| PT89713A (pt) | Processo para a preparacao de antagonistas tetrazolicos de receptores de amino-acidos excitadores | |
| FI874789L (fi) | Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja | |
| HUT51295A (en) | Process for producing peptidalcohol derivatives of anticoagulant activity | |
| ATE109136T1 (de) | Substituierte cyclohexene mit zentraler nervensystem-wirkung. | |
| PT86619A (pt) | Process for preparing alkylmelatonins | |
| PT87946A (pt) | Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno | |
| PT84648B (pt) | Processo para a preparacao de tia-ciclo alqueno 3,2-b piridinas substituidas e de composicoes farmaceuticas que as contem | |
| ATE113949T1 (de) | Alpha-adrenergische rezeptorantagonisten. | |
| SE8300289L (sv) | 3,3-dialkyl- och 3,3-alkylen-indolinderivat, sett att framstella dessa och farmaceutiska kompositioner innehallande desamma | |
| FI881075A7 (fi) | Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi | |
| KR870700627A (ko) | 세팔로스포린 유도체의 신규 제조방법 | |
| FI890309A0 (fi) | Parannettu menetelmä tiotepan valmistamiseksi | |
| HU893309D0 (en) | Process for producing antagonists of alpha-adrenergic receptor and pharmaceutical preparatives containing these compounds | |
| ES529046A0 (es) | Mejoras introducidas en el objeto de la patente principal n 513.469, por: procedimiento para preparar derivados de pirimidona | |
| GR1000302B (el) | Μεθοδος παρασκευης παραγωγων 2,4-διυδρο-3η-1,2,4-τριαζολ-3-ονης. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19940822 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20020228 |